πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10626399

Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10611816

Anti-KRAS-G12D T cell receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10614684

Treatment of kidney diseases associated with elevated AVP

THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE Β· Granted Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10611815

T cell receptors recognizing MHC class II-restricted MAGE-A3

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10604582

Anti-CD276 antibodies (B7H3)

The United States of America, as represented by the Secretary, Department of Health Β· Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10603296

Compositions and methods for diagnosis and treatment of neuromuscular disorders

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10604499

MYC G-quadruplex stabilizing small molecules and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10604548

Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof

The Government of the United States of America, as represented by the Secretary of Homeland Security Β· Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10596185

Flavonoid compositions and uses thereof

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10596227

Polypeptide targeting to mitochondria

United Kingdom Research and Innovation Β· Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10590074

Potent and selective inhibitors of monoamine transporters; method of making; and use there

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10588984

Virus-like particle conjugates for diagnosis and treatment of tumors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10583173

Methods of treating or preventing pruritis by blocking natriuretic polypeptide b

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10584161

Monoclonal antibodies specific for heartland virus and methods of their use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10584355

Chimpanzee adenoviral vector-based filovirus vaccines

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services Β· Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10583159

Method for increasing performance of offspring

UNITED ANIMAL HEALTH, INC. Β· Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10583148

Methods and devices for bone infection treatment selection

The United States Government Β· Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10577349

Quinolinones as inhibitors of translation initiation complex

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10577368

A3 adenosine receptor agonists

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10576091

Tomatidine, analogs thereof, compositions comprising same, and uses for same

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10576059

Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

The United States of America, as Represented by the Secretary, Department of Human Services Β· Granted Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10570214

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of sa

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10568873

Safranal-sorafenib combination therapy for liver cancer

UNITED ARAB EMIRATES UNIVERSITY Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10568956

Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominan

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted